Methylprednisolone Administration Following Spinal Cord Injury Reduces Aquaporin 4 Expression and Exacerbates Edema
Spinal cord injury (SCI) is an incapacitating condition that affects motor, sensory, and autonomic functions. Since 1990, the only treatment administered in the acute phase of SCI has been methylprednisolone (MP), a synthetic corticosteroid that has anti-inflammatory effects; however, its efficacy r...
Saved in:
| Main Authors: | Eibar Ernesto Cabrera-Aldana, Fernando Ruelas, Cristina Aranda, Ruth Rincon-Heredia, Angelina Martínez-Cruz, Alejandro Reyes-Sánchez, Gabriel Guizar-Sahagún, Luis B. Tovar-y-Romo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2017/4792932 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of aquaporins in brain water transport and edema
by: Yuyuan Li, et al.
Published: (2025-01-01) -
Recombinant human erythropoietin plus methylprednisolone versus methylprednisolone in treatment of acute spinal cord injury:protocol for a systematic review and meta-analysis
by: Yu He, et al.
Published: (2022-12-01) -
Mega-dose methylprednisolone versus pulse methylprednisolone
by: Sinasi Ozsoylu
Published: (2014-04-01) -
Methylprednisolone substituted lipid nanoparticles deliver C3 transferase mRNA for combined treatment of spinal cord injury
by: Haoru Dong, et al.
Published: (2025-02-01) -
Emerging Role of Spinal Cord TRPV1 in Pain Exacerbation
by: Seung-In Choi, et al.
Published: (2016-01-01)